Abstract P4-22-18: phase Ib safety, efficacy, and molecular analysis of ribociclib (LEE011) plus letrozole for the treatment of ER+, HER2– advanced breast cancer
Munster, P Ismail-Khan, R Garcia-Estevez, L Mayer, I Becerra, C Hamilton, E De Boer, R Im, S Teixeira, L
Munster, P
Ismail-Khan, R
Garcia-Estevez, L
Mayer, I
Becerra, C
Hamilton, E
De Boer, R
Im, S
Teixeira, L
Citations
Altmetric:
Abstract
Description
Date
2017-02-14
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Abstract P4-22-18: phase Ib safety, efficacy, and molecular analysis of ribociclib (LEE011) plus letrozole for the treatment of ER+, HER2– advanced breast cancer 2017, 77 (4 Supplement):P4-22-18 Cancer Research